reports
- Jonathan Moreland
RGP RESOURCES CONNECTION INC.
RDNT RADNET INC.
PBF PBF ENERGY INC. CLASS A
OMI OWENS & MINOR INC.
NEOG NEOGEN CORPORATION
MOD MODINE MANUFACTURING COMPANY
CVGW CALAVO GROWERS INC.
CRM SALESFORCE.COM INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
APA.. APA CORP.
LPG DORIAN LPG
WHF WHITEFIELD
AB ALLIANCEBERNSTEIN HOLDING L.P.
ADC AGREE REALTY CORPORATION
AMTX AEMETIS
CNFR CONIFER HOLDINGS
MSM MSC INDUSTRIAL DIRECT CO. INC. CLASS A
KYN KAYNE ANDERSON MLP INVESTMENT CO.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
NHF NEXPOINT CREDIT STRATEGIES FUN
WGO WINNEBAGO INDUSTRIES INC.
FF FIRST MINING GOLD
DOMO DOMO INCORPORATED
SONO SONOS
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
LPI LAREDO PETROLEUM INC.
KROS KEROS THERAPEUTICS
ASAN ASANA
PCVX VAXCYTE
NUVB NUVATION BIO INC (A)
UAN CVR PARTNERS LP
SMMT SUMMIT THERAPEUTICS INC
FTCI FTC SOLAR
PFBX INC.
HUMA PEOPLES FINANCIAL CORP. (MISSISSIPPI)
PEPG HUMACYTE INC
EWTX PEPGEN INC
GLSI EDGEWISE THERAPEUTICS INC
JMSB GREENWICH LIFESCIENCES INC
MEGI JOHN MARSHALL BANCORP INC
NMTC MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
ERNA NEUROONE MEDICAL TECHNOLOGIES CORP
VANI ETERNA THERAPEUTICS INC.
GTE VIVANI MEDICAL INC
SBGI GRAN TIERRA ENERGY INC.
BATRK SINCLAIR INC
ECF LIBERTY MEDIA CORPORATION
ELLSWORTH FUND LTD
- Jonathan Moreland
TDOC TELADOC HEALTH INC.
SAIC SCIENCE APPLICATIONS INTERNATIONAL CORP.
RGP RESOURCES CONNECTION INC.
RDNT RADNET INC.
OPK OPKO HEALTH INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
AMTX AEMETIS
CNFR CONIFER HOLDINGS
KYN KAYNE ANDERSON MLP INVESTMENT CO.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
CMPX COMPASS THERAPEUTICS
NUVB INC.
HUMA NUVATION BIO INC (A)
BUKS HUMACYTE INC
GLSI BUTLER NATIONAL CORP
VANI GREENWICH LIFESCIENCES INC
GTE VIVANI MEDICAL INC
EVM GRAN TIERRA ENERGY INC.
EATON VANCE INSD CALIF MUN BD FD
- Jonathan Moreland
PBF PBF ENERGY INC. CLASS A
OMI OWENS & MINOR INC.
MOD MODINE MANUFACTURING COMPANY
CMC COMMERCIAL METALS COMPANY
ALDX ALDEYRA THERAPEUTICS
KYN KAYNE ANDERSON MLP INVESTMENT CO.
JELD JELD-WEN HOLDING INC.
NHF NEXPOINT CREDIT STRATEGIES FUN
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
ZYME ZYMEWORKS INC.
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
LPI LAREDO PETROLEUM INC.
ASAN ASANA
PCVX VAXCYTE
UAN CVR PARTNERS LP
ZIP ZIPRECRUITER
PFBX INC.
BTMD PEOPLES FINANCIAL CORP. (MISSISSIPPI)
TEAF HAYMAKER ACQUISITION CORP III
GLSI ECOFIN SUSTAINABLE AND SOCIAL IMPACT TERM FUND
MEGI GREENWICH LIFESCIENCES INC
NMTC MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
SBGI NEUROONE MEDICAL TECHNOLOGIES CORP
CVI SINCLAIR INC
NYC CVR ENERGY
EU INC.
ECF NEW YORK CITY REIT
INC.
WISDOMTREE EURO DEBT FUND
ELLSWORTH FUND LTD
- Jan Frederik Slijkerman
- Jeroen van den Broek
- Jesse Norcross
- Nadège Tillier
- Timothy Rahill
Greenwich LifeSciences Provides Global Update on FLAMINGO-01
Greenwich LifeSciences Provides Global Update on FLAMINGO-01 STAFFORD, Texas, April 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following global update on FLAMINGO-01. Flamingo-01 Progress to Date & Future Plans The Company recently confirmed that the preliminary HLA prevalence, safety, and immune response data in FLAMINGO-01 patients is trendi...
Greenwich LifeSciences Announces Positive Immune Response Data from FL...
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the following update on FLAMINGO-01 open label immune response data. FLAMINGO-01 Immune Response Data Summary The Company has analyzed the preliminary immune response data from ...
Greenwich LifeSciences Extends Lock-up of Directors and Officers to Ma...
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026 STAFFORD, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced that its Board of Directors has extended the lock-up of the shares owned by the Company's directors, officers, and existing pre-IPO investors to March 31, 2026 which is approximately 66 months from dat...
Barnwell Industries Corrects Ned Sherwood’s Misleading Claims
Barnwell Industries Corrects Ned Sherwood’s Misleading Claims Alex Kinzler does NOT support Sherwood’s Consent Solicitation Consent Submitted by Alex Kinzler for One Share Required to Commence Consent Solicitation Urges Shareholders to Ignore and Discard any Blue Consent Solicitation Card HONOLULU, March 19, 2025 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE American: BRN) (“Barnwell” or the “Company”) today corrected the record regarding Ned Sherwood’s highly misleading statements made in connection with his attempt to take over Barnwell without paying a premium to shareho...
Greenwich LifeSciences Provides Update on Open Label Safety Data from ...
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01 STAFFORD, Texas, March 17, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the following update on FLAMINGO-01 open label safety data. FLAMINGO-01 Data Safety Monitoring Board (DSMB) The FLAMINGO-01 DSMB met twice in 2024, most recently in December 2024, and recommended to c...
Barnwell Industries, Inc. Announces Sale of its Water Drilling Subsidi...
Barnwell Industries, Inc. Announces Sale of its Water Drilling Subsidiary for $1,050,000 Sale Will Streamline Parent Company Operations to Focus on Oil and Natural Gas Business HONOLULU, March 17, 2025 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE American: BRN) (“Barnwell” or the “Company”) today announced the sale of its wholly owned subsidiary, Water Resources International, Inc. (“Water Resources”), a deep drilling and well pumping specialist in the exploration and development of groundwater resources for government, commercial and private clients in Hawaii, for $1,050,000. Pr...
Barnwell Industries, Inc. Disqualifies Ned Sherwood’s Board Nominees I...
Barnwell Industries, Inc. Disqualifies Ned Sherwood’s Board Nominees Included in Defective and Insufficient Nomination Notice for 2025 Annual Meeting Sets March 14, 2025, as Record Date for Shareholders to Act by Written Consent in Connection with Sherwood’s Latest Self-Serving Campaign to Take Control of Barnwell Sherwood’s Consent Solicitation is Yet Another Attempt to Steal the Company from Shareholders Without Paying a Premium for Control HONOLULU, March 05, 2025 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE American: BRN) (“Barnwell” or the “Company”) today announced that the...
Barnwell Industries, Inc. Announces Entering into a Non-Binding Letter...
Barnwell Industries, Inc. Announces Entering into a Non-Binding Letter of Intent for the Sale of its Water Well Drilling Subsidiary HONOLULU, March 05, 2025 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE American: BRN) (“Barnwell” or the “Company”) today announced that it had entered into a non-binding letter of intent for the sale of Water Resources International, Inc., its water well drilling subsidiary. The Company anticipates that the transaction, for an expected aggregate value of $1,050,000, would close in late March 2025. A portion of the consideration would be paid at the clo...
Barnwell Industries, Inc. Informs Ned Sherwood of Defective and Insuff...
Barnwell Industries, Inc. Informs Ned Sherwood of Defective and Insufficient Director Nomination Notice and Investigation of Circumstances that May Have Triggered Shareholder Rights Plan Actions Continue Ned Sherwood’s Long History of Disruption, Breaches of Settlement Agreements and Blatant Disregard for Established Bylaws and Shareholder Protections Board Forms Executive Committee to Protect Shareholder Interests Executive Committee Believes Sherwood’s Nomination of Himself, His Friends and His Affiliates Underscores Desire to Take Control of Barnwell at Shareholders’ Expense a...
- Jan Frederik Slijkerman
- Jeroen van den Broek
- Jesse Norcross
- Nadège Tillier
- Timothy Rahill
ServisFirst Bancshares Inc: 1 director
A director at ServisFirst Bancshares Inc sold 18,000 shares at 88.680USD and the significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Barnwell Industries, Inc. Reports Results for its First Quarter Ended ...
Barnwell Industries, Inc. Reports Results for its First Quarter Ended December 31, 2024 HONOLULU, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE American: BRN) today reported financial results for its first quarter ended December 31, 2024. For the quarter, the Company had revenue of $4,477,000 and a net loss of $1,917,000 or $0.19 per share. In the three months ended December 31, 2023, the Company reported quarterly revenue of $6,155,000 and a net loss of $664,000 or $0.07 per share. The Company remains debt free and ended the quarter with $642,000 in working capital, i...
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLA...
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 STAFFORD, Texas, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the following update on FLAMINGO-01 open label HLA data. Analysis of the open label data from FLAMINGO-01 has commenced and has been conducted in a manner that maintains the study blind. A preliminary rev...
- Jonathan Moreland
OPK OPKO HEALTH INC.
NEOG NEOGEN CORPORATION
LNDC LANDEC CORP.
LAKE LAKELAND INDUSTRIES INC.
CTSO CYTOSORBENTS
FRD FRIEDMAN INDUSTRIES INC.
ESQ ESQUIRE FINANCIAL HOLDINGS
MPB MID PENN BANCORP INC.
ETST EARTH SCIENCE TECH
ANIX ANIXA BIOSCIENCES
LBSRD LIBERTY STAR URANIUM & METALS
ALLY GMAC LLC
ACXP ACURX PHARMACEUTICALS INC
GLSI GREENWICH LIFESCIENCES INC
TLSI TRISALUS LIFE SCIENCES INC
PCSA PROCESSA PHARMACEUTICALS INC
MXF THE MEXICO FUND
AMST INC.
MYCB AMESITE INC.
MY CITY BUILDERS
INC.
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01...
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe STAFFORD, Texas, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following update on the expansion of the clinical trial into Europe. The Company's application to add an additional 11 sites in Spain, Germany, and Poland has been formally approved by EMA. The acade...
Barnwell Industries, Inc. Adopts Limited-Duration Shareholder Rights P...
Barnwell Industries, Inc. Adopts Limited-Duration Shareholder Rights Plan Designed to Prevent “Creeping” Control by 30% Shareholder and Protect the Long-Term Value for All Shareholders HONOLULU, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE American: BRN) (“Barnwell” or the “Company”) today announced that the Board of Directors (the “Board”) of Barnwell has adopted a limited-duration shareholder rights plan (“Rights Plan”) designed to protect the interests of the Company and all of its shareholders. The Rights Plan is also intended to provide the Board sufficient tim...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.